NGL Fine-Chem - Quaterly Results

02 May 2022 Evaluate
A fair growth of 8.95% in the revenue at Rs. 782.13 millions was reported in the March 2022 quarter as compared to Rs. 717.89 millions during year-ago period.Profit after Tax for the quarter ended March 2022 saw a decline of -45.08% from Rs. 143.07 millions to Rs. 78.58  millions.The Operating Profit of the company witnessed a decrease to 122.72 millions from 233.54 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 782.13 717.89 8.95 3186.67 2552.07 24.87 3186.67 2552.07 24.87
Other Income 22.79 25.35 -10.10 126.40 115.21 9.71 126.40 115.21 9.71
PBIDT 122.72 233.54 -47.45 782.09 852.30 -8.24 782.09 852.30 -8.24
Interest 3.74 3.27 14.37 15.62 18.40 -15.11 15.62 18.40 -15.11
PBDT 118.98 230.27 -48.33 766.47 833.90 -8.09 766.47 833.90 -8.09
Depreciation 18.80 18.52 1.51 76.73 73.94 3.77 76.73 73.94 3.77
PBT 100.18 211.75 -52.69 689.74 759.96 -9.24 689.74 759.96 -9.24
TAX 21.60 68.68 -68.55 167.28 205.28 -18.51 167.28 205.28 -18.51
Deferred Tax -8.90 2.08 -527.88 -4.22 14.58 -128.94 -4.22 14.58 -128.94
PAT 78.58 143.07 -45.08 522.46 554.68 -5.81 522.46 554.68 -5.81
Equity 30.89 30.89 0.00 30.89 30.89 0.00 30.89 30.89 0.00
PBIDTM(%) 15.69 32.53 -51.77 24.54 33.40 -26.51 24.54 33.40 -26.51

NGL Fine-Chem Share Price

1343.30 29.75 (2.26%)
15-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.25
Dr. Reddys Lab 1280.40
Cipla 1507.25
Zydus Lifesciences 921.25
Lupin 2090.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×